CD22 CAR T Cells Show Relatively Mild Neurotoxicity, Study Finds
Investigators found important differences that may help clinicians better understand how to manage toxicities associated with the therapy.
Source: ajmc.com
Niralin Shah News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Niralin Shah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Niralin Shah Today - Breaking & Trending Today
CAR-T Therapy in Pediatric Leukemia: Past, Present, and Future
The FDA approval of the first CAR T-cell therapy for children and young adults with B-cell ALL changed the treatment paradigm for this disease.
Source: cancertherapyadvisor.com
BLOG: CAR T-cells for long-term cure in pediatric ALL
Blogs | | Chimeric antigen receptor T-cell therapy targeting CD19 is highly effective for inducing remission among patients with relapsed or refractory B-cell acute lymphoblastic leukemia.Despite that, 50% of patients relapse after CAR-T therapy, and curative options for patients who relapse after CD19 CAR-T are limited, with no standard approach to cure.
Source: healio.com
CAR-T Therapy in Pediatric Leukemia: Past, Present, and Future
The FDA approval of the first CAR T-cell therapy for children and young adults with B-cell ALL changed the treatment paradigm for this disease.
Source: oncologynurseadvisor.com
Year in Review: Acute Lymphoblastic Leukemia
New ways to use CAR T-cell therapy and treatment de-intensification strategies
Source: medpagetoday.com